Interactions between Microbiome and DME (MICBIO)
|
Bacteria: Actinobacteria |
Bifidobacterium adolescentis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bifidobacterium adolescentis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bifidobacterium breve (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bifidobacterium breve co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bifidobacterium longum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bifidobacterium longum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
Eggerthella lenta (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Eggerthella lenta co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteria: Bacteroidetes |
Bacteroides cellulosilyticus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides cellulosilyticus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides dorei co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides fragilis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides intestinalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides intestinalis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides sartorii co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides thetaiotaomicron co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides uniformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides vulgatus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Bacteroides xylanisolvens co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Odoribacter splanchnicus co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Parabacteroides distasonis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Parabacteroides distasonis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Parabacteroides johnsonii co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Parabacteroides merdae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Parabacteroides merdae co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Prevotella copri co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteria: Firmicutes |
Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Clostridium botulinum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Clostridium perfringens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Clostridium perfringens co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
Enterocloster asparagiformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Enterocloster asparagiformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Eubacterium limosum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Eubacterium limosum co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Holdemanella biformis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteria: Fusobacteria |
Fusobacterium varium (fusobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Fusobacterium varium co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [3] |
Bacteria: Lentisphaerae |
Victivallis vadensis (PVC bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Lovastatin |
Click to Show/Hide the Detail |
Drug ID |
DR0986
Drug Info
|
Interaction Mechanism |
Human Serum paraoxonase/lactonase 3 (PON3) and Victivallis vadensis co-metabolize the drug Lovastatin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
|
|
|
|
|
|